Journal article
Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection
Journal of Virology, Vol.82(18), pp.9216-9227
2008
Abstract
During acute human immunodeficiency virus type 1 (HIV-1) infection, early host cellular immune responses drive viral evolution. The rates and extent of these mutations, however, remain incompletely characterized. In a cohort of 98 individuals newly infected with HIV-1 subtype B, we longitudinally characterized the rates and extent of HLA-mediated escape and reversion in Gag, Pol, and Nef using a rational definition of HLA-attributable mutation based on the analysis of a large independent subtype B data set. We demonstrate rapid and dramatic HIV evolution in response to immune pressures that in general reflect established cytotoxic T-lymphocyte (CTL) response hierarchies in early infection. On a population level, HLA-driven evolution was observed in ∼80% of published CTL epitopes. Five of the 10 most rapidly evolving epitopes were restricted by protective HLA alleles (HLA-B*13/B*51/B*57/B*5801; P = 0.01), supporting the importance of a strong early CTL response in HIV control. Consistent with known fitness costs of escape, B*57-associated mutations in Gag were among the most rapidly reverting positions upon transmission to non-B*57-expressing individuals, whereas many other HLA-associated polymorphisms displayed slow or negligible reversion. Overall, an estimated minimum of 30% of observed substitutions in Gag/Pol and 60% in Nef were attributable to HLA-associated escape and reversion events. Results underscore the dominant role of immune pressures in driving early within-host HIV evolution. Dramatic differences in escape and reversion rates across codons, genes, and HLA restrictions are observed, highlighting the complexity of viral adaptation to the host immune response.
Details
- Title
- Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection
- Authors/Creators
- Z. L. Brumme (Author/Creator) - Harvard UniversityC. J. Brumme (Author/Creator) - Harvard UniversityJ. Carlson (Author/Creator) - Microsoft (United States)H. Streeck (Author/Creator) - Harvard UniversityM. John (Author/Creator) - Royal Perth HospitalQ. Eichbaum (Author/Creator) - Harvard UniversityB. L. Block (Author/Creator) - Harvard UniversityB. Baker (Author/Creator) - Harvard UniversityC. Kadie (Author/Creator) - Microsoft (United States)M. Markowitz (Author/Creator) - Aaron Diamond AIDS Research CenterH. Jessen (Author/Creator) - Jessen-Praxis, Berlin, GermanyA. D. Kelleher (Author/Creator) - UNSW SydneyE. Rosenberg (Author/Creator) - Harvard UniversityJ. Kaldor (Author/Creator) - UNSW SydneyY. Yuki (Author/Creator) - Science Applications International Corporation (United States)M. Carrington (Author/Creator) - Leidos (United States)T. M. Allen (Author/Creator) - Harvard UniversityS. Mallal (Author/Creator) - Royal Perth HospitalM. Altfeld (Author/Creator) - Harvard UniversityD. Heckerman (Author/Creator) - Microsoft (Canada)B. D. Walker (Author/Creator) - Howard Hughes Medical Institute
- Publication Details
- Journal of Virology, Vol.82(18), pp.9216-9227
- Publisher
- American Society for Microbiology
- Identifiers
- 991005544889407891
- Copyright
- © 2008, American Society for Microbiology
- Murdoch Affiliation
- Centre for Clinical Immunology and Biomedical Statistics
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
252 File views/ downloads
101 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.66 HIV
- 1.66.46 HIV Pathogenesis
- Web Of Science research areas
- Virology
- ESI research areas
- Microbiology